Discontinued — last reported Q3 '23

Equity

Convertible Preferred Stock Authorized Shares

Medline, Inc. Convertible Preferred Stock Authorized Shares remained flat by 0.0% to 5B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ2 2019
Last reportedQ3 2023

How to read this metric

An increase in authorized shares provides greater capital-raising flexibility but may signal potential future dilution for common shareholders.

Detailed definition

This represents the maximum number of convertible preferred shares that the company is legally permitted to issue under...

Peer comparison

Standard corporate governance metric; levels are usually set high to provide long-term flexibility.

Metric ID: convertible_preferred_stock_authorized_shares

Historical Data

2 periods
 Q4 '25Q1 '26
Value5B5B
QoQ Change+0.0%
Range5B5B

Convertible Preferred Stock Authorized Shares at Other Companies

Frequently Asked Questions

What is Medline, Inc. 's convertible preferred stock authorized shares?
Medline, Inc. (MDLN) reported convertible preferred stock authorized shares of 5B in Q1 2026.
What does convertible preferred stock authorized shares mean?
The maximum number of convertible preferred shares the company is allowed to issue.